ABTIS
Live / Registered — Registered (as of 12 May 2020)
What this means for you
Registered since 12 May 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79264508
- Registration number
- 6050283
- Mark type
- Stylized text
- Filed
- 19 Jun 2019
- Published for opposition
- 25 Feb 2020
- Registered
- 12 May 2020
- Attorney of record
- Paul G. Johnson
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical agents affecting metabolism; pharmaceutical preparations for treating metabolic disorders; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical products for the treatment of cancer; chemical preparations for pharmaceutical purposes, namely, for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; biotechnological preparations for medical purposes, namely, for the treatment of oncological, metabolic and ophthalmic diseases and disorders; drugs for medical purposes, namely, for treating cancer; drugs for medical purposes, namely, for treating diabetes; drugs for medical purposes, namely, for treating ocular disease; antibodies for medical purposes, namely, for the treatment of oncological, metabolic and ophthalmic diseases and disorders; pharmaceutical compositions for the treatment of oncological, metabolic and ophthalmic diseases and disorders; medicines for human purposes for the treatment of oncological, metabolic and ophthalmic diseases and disorders; nutraceuticals for therapeutic purposes for the treatment of cancer; nutraceuticals for therapeutic purposes for the treatment of diabetes; therapeutic drugs and agents, namely, antibody drug conjugate comprising antibody and chemical compound attached for the treatment of oncological, metabolic and ophthalmic diseases and disorders; anti-cancer preparations
- Class 042 — Scientific and technological services: Research and development of vaccines and medicines; biotechnology research; biological research; crude medicines research; scientific research for medical purposes in the field of cancerous diseases; research on the subject of pharmaceuticals; medical research; clinical research in the field of oncology, metabolic disease and ophthalmology
Owner
- AbTis Co., Ltd., KR
- AbTis Co., Ltd., KR
- AbTis Co., Ltd., KR
Prosecution history
- 02 Apr 2026 — NEW REPRESENTATIVE AT IB RECEIVED
- 12 May 2025 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 28 Jan 2022 — NEW REPRESENTATIVE AT IB RECEIVED
- 11 Oct 2020 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 17 Sept 2020 — FINAL DISPOSITION NOTICE SENT TO IB
- 17 Sept 2020 — FINAL DISPOSITION PROCESSED
- 12 Aug 2020 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 12 May 2020 — REGISTERED-PRINCIPAL REGISTER
- 25 Feb 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Feb 2020 — PUBLISHED FOR OPPOSITION
- 22 Feb 2020 — NOTIFICATION PROCESSED BY IB
- 05 Feb 2020 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 05 Feb 2020 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 05 Feb 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 23 Jan 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER